ZYMAGENX
Live / Applied — Non-final action mailed (as of 23 Jan 2026)
What this means for you
Not registered yet, but its 12 May 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99179766
- Mark type
- Stylized text
- Filed
- 12 May 2025
- Attorney of record
- Phillip Thomas Horton
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment and prevention of celiac disease; Pharmaceutical products for the treatment of autoimmune diseases, namely, celiac disease; Pharmaceutical preparations for the treatment of autoimmune diseases; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes
- Class 042 — Scientific and technological services: Pharmaceutical products development; Pharmaceutical research services; Providing medical and scientific research information in the field of clinical trials; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials
Owner
- ZymagenX, Inc., Newport Beach, CA, US
Prosecution history
- 23 Jan 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 23 Jan 2026 — NON-FINAL ACTION E-MAILED
- 23 Jan 2026 — NON-FINAL ACTION WRITTEN
- 02 Jan 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 02 Jan 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 02 Jan 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 02 Oct 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 02 Oct 2025 — NON-FINAL ACTION E-MAILED
- 02 Oct 2025 — NON-FINAL ACTION WRITTEN
- 25 Sept 2025 — ASSIGNED TO EXAMINER
- 19 Sept 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 12 May 2025 — APPLICATION FILING RECEIPT MAILED
- 12 May 2025 — NEW APPLICATION ENTERED